GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a...

GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose-Exposure Relationships to Define Clinical Development Strategies

Hirankarn, Sarapee, Barrett, Jeffrey S., Alamuddin, Naji, FitzGerald, Garret A., Skarke, Carsten
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Language:
english
Journal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.47
Date:
October, 2013
File:
PDF, 1.33 MB
english, 2013
Conversion to is in progress
Conversion to is failed